P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 20 March 2018 | 8:29 pm

Responding Disruptively to a Most Profound Disruption: Working to Help Childhood Cancer Survivors

March 20, 2018 | By Murdo Gordon, Chief Commercial Officer, Bristol-Myers Squibb more ...

Published 20 March 2018 | 5:46 pm

How We Revolutionized Diabetes Care

To provide an innovative solution to help people with diabetes manage their condition, Abbott had to reinvent its initial product concept. more ...

Published 20 March 2018 | 4:11 pm

Building "boot camps" for immune cells near tumors

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer. more ...

Published 20 March 2018 | 12:34 pm

GSK starts phase III study of Benlysta and rituximab combination in systemic lupus erythematosus

GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus more ...

Published 20 March 2018 | 11:48 am

OLEDWorks partners with BASF to introduce new OLED lighting technology with high efficiency and high flexibility

Münster/Germany and Aachen/Germany, March 20, 2018 - OLEDWorks, leading manufacturer of OLED lighting panels, and BASF's Coatings division, expert for high-quality more ...

Published 20 March 2018 | 8:06 am

Completion of Takeda Global Headquarters

Takeda, with a global presence that spans more than 70 countries and regions, completes the construction of new company building in Tokyo, named "Takeda Global more ...

Published 20 March 2018 | 7:19 am

Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies

Collaboration and licensing agreement combine Harvard's expertise in tumor biology and materials science with Novartis'diverse immuno-oncology pipeline more ...

Published 20 March 2018 | 7:15 am

Media Release

Phase III IMpower131 study showed Roche's TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the more ...

Published 19 March 2018 | 9:35 pm

U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

sNDA Seeks to Expand the Indication of XTANDI to include Men with Non-metastatic CRPC more ...

Published 19 March 2018 | 8:41 pm

EX Conference - A Decade of Innovation

For the past 10 years, Pfizer has been bringing together colleagues from around the globe for its annual EX innovation conference. The location and focus for the conference more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Berlin, September 26 – 29, 2017

Next Annual General Meeting, Berlin, September 26 – 29, 2017